Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$12.91
+5.09%
Mkt Cap $1.57B
Analyst Ratings
Buy
6
Hold
4
Sell
1
Price Target (58 analysts)
$21.64
Range $8.00 – $49.00
Implied Upside
+67.7%
Consensus $21.64 vs current $12.91
NASDAQ·Healthcare·Biotechnology
$12.91
+5.09%
Mkt Cap $1.57B
Buy
6
Hold
4
Sell
1
Price Target (58 analysts)
$21.64
Range $8.00 – $49.00
+67.7%
Consensus $21.64 vs current $12.91